Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CyGenica gets $1.4 million funding from SOSV for cancer and rare genetic disease therapy
Other investors participating in the round included the VOYAGER Health-Tech fund, David Rowan, founder of Voyagers.io, and angel…
Build a tech-driven career in healthcare with Pharma Management at NMIMS
NMIMS grooms skilled healthcare professionals to build a successful career in the fast-developing pharma industry by providing a…
Syngene appoints Sanjeev Sukumaran as CHRO
Sukumaran joined Syngene in October 2017 as the Chief of Staff and was responsible for driving key strategic initiatives across…
Biogen gets US FDA accelerated approval for Aduhelm to treat Alzheimer’s
It is the first new treatment approved for Alzheimer's since 2003 and is the first therapy that targets the fundamental…
Researchers at ILS Bhubaneshwar develop animal models to study coronavirus
Animal models that closely resemble the pathogenesis of SARS-CoV-2-induced disease in humans are essential for research on disease…
Lupin gets USFDA nod to market generic HIV drug
The company has received approval from the United States Food and Drug Administration (USFDA) to market its emtricitabine and…
CSIR and Laxai Life Sciences begin phase II trial of niclosamide drug to treat COVID-19
Niclosamide has been extensively used in the past for treating tapeworm infection in adults as well as children
NMPB and CSIR-NBRI sign MoU for promoting cultivation and production of medicinal plants
Through this collaboration, NMPB will support CSIR-NBRI in carrying out the potential medicinal plant species with high commercial…
QAI conducts first internal auditor training for biobanking
Accreditation of biobanks would facilitate harmonisation of practices among biobanks, researchers and other parties including…
Sustainability and sustainable development in pharma industry
Prasad Jaladi, Founder and Chief Facilitator, and Mahmood Sabahi, Sustainable Chemistry expert, Suraksha, point out that leading…